practical considerations with nintedanib in lung adenocarcinoma
Published 7 years ago • 346 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
3:01
nintedanib in lung adenocarcinoma: managing toxicities
-
5:59
practical implications of the lume-lung 1 findings
-
6:45
lung adenocarcinoma: patient selection with ramucirumab vs nintedanib
-
5:07
differentiating among anti-vegf therapies in lung adenocarcinoma
-
4:25
cost considerations in non-driver nsclc management
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
8:36
case study: mutation-negative patient with lung adenocarcinoma
-
3:24
nondriver lung adenocarcinoma: treatment considerations
-
1:55
dr. heather wakelee discusses nintedanib plus chemotherapy in nsclc
-
4:05
sequencing therapies in advanced lung adenocarcinoma
-
3:55
the future of non-driver lung adenocarcinoma
-
5:20
asco lung cancer highlights, pt 11: nintedanib with second line chemotherapy
-
1:59
dr. tolba on the use of afatinib in nrg1-mutated lung adenocarcinoma
-
5:37
diagnosing lung adenocarcinoma: biopsying adequate tissue
-
0:58
ngs testing necessary for treatment of lung adenocarcinoma
-
1:44
dr reuss on the investigation of lp-300 in lung adenocarcinoma
-
3:11
nintedanib plus steroid taper in radiation pneumonitis
-
7:23
chemotherapy for advanced lung cancer
-
7:12
treatment approach for nondriver lung adenocarcinoma